Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP1244756.RAcPoycM_vSXtxYZ3U_UqmfpRsLCFF2GZmSlQElDKB2TQ130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP1244756.RAcPoycM_vSXtxYZ3U_UqmfpRsLCFF2GZmSlQElDKB2TQ130_assertion type Assertion NP1244756.RAcPoycM_vSXtxYZ3U_UqmfpRsLCFF2GZmSlQElDKB2TQ130_head.
- NP1244756.RAcPoycM_vSXtxYZ3U_UqmfpRsLCFF2GZmSlQElDKB2TQ130_assertion description "[Testing of rapamycin in combination with insulin sensitizers is warranted, as such compounds may ameliorate the putative negative effects of rapamycin in the type 2 diabetes environment.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1244756.RAcPoycM_vSXtxYZ3U_UqmfpRsLCFF2GZmSlQElDKB2TQ130_provenance.
- NP1244756.RAcPoycM_vSXtxYZ3U_UqmfpRsLCFF2GZmSlQElDKB2TQ130_assertion evidence source_evidence_literature NP1244756.RAcPoycM_vSXtxYZ3U_UqmfpRsLCFF2GZmSlQElDKB2TQ130_provenance.
- NP1244756.RAcPoycM_vSXtxYZ3U_UqmfpRsLCFF2GZmSlQElDKB2TQ130_assertion SIO_000772 25473963 NP1244756.RAcPoycM_vSXtxYZ3U_UqmfpRsLCFF2GZmSlQElDKB2TQ130_provenance.
- NP1244756.RAcPoycM_vSXtxYZ3U_UqmfpRsLCFF2GZmSlQElDKB2TQ130_assertion wasDerivedFrom befree-2016 NP1244756.RAcPoycM_vSXtxYZ3U_UqmfpRsLCFF2GZmSlQElDKB2TQ130_provenance.
- NP1244756.RAcPoycM_vSXtxYZ3U_UqmfpRsLCFF2GZmSlQElDKB2TQ130_assertion wasGeneratedBy ECO_0000203 NP1244756.RAcPoycM_vSXtxYZ3U_UqmfpRsLCFF2GZmSlQElDKB2TQ130_provenance.